Trial Outcomes & Findings for Impact of Deep Versus Standard Muscle Relaxation on Intra-operative Safety (NCT NCT04124757)

NCT ID: NCT04124757

Last Updated: 2025-06-11

Results Overview

The incidence of symptomatic intra-operative adverse events requiring intervention or treatment (ClassIntra®grade \>1) during laparoscopic surgery in the standard of care versus the deep NMB group, as scored by the attending surgeon and anesthesiologist at the end of every procedure. A recent update of the ClassIntra®grade also involved intraoperative adverse events related to anesthesia \[Gawria et al 2023\]. This study will use both the original classic scoring, as well as an adapted version of the updated classic scoring system. The Classic score; classification of intraoperative complications, is a 6 point scale ranging from no complications (0) to fatal complications (5).

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

731 participants

Primary outcome timeframe

Day of surgery

Results posted on

2025-06-11

Participant Flow

Participant milestones

Participant milestones
Measure
Standard Neuromuscular Blockade
Subjects will receive regular rocuronium induction dose, followed by bolus foses of 10 mg in case of insufficient conditions
Deep Neuromuscular Block
Subjects will receive high dose rocuronium induction dose followed by continuous rocuronium administration, to achieve a depth of neuromuscular block of 1-2 twitches post tetanic count Deep neuromuscular block: Deep neuromuscular block will be achieved with high dose rocuronium to achieve a depth of 1-2 twitches post tetanic count
Overall Study
STARTED
367
364
Overall Study
COMPLETED
365
363
Overall Study
NOT COMPLETED
2
1

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Impact of Deep Versus Standard Muscle Relaxation on Intra-operative Safety

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Standard Neuromuscular Blockade
n=362 Participants
Subjects will receive regular rocuronium induction dose, followed by bolus foses of 10 mg in case of insufficient conditions
Deep Neuromuscular Block
n=361 Participants
Subjects will receive high dose rocuronium induction dose followed by continuous rocuronium administration, to achieve a depth of neuromuscular block of 1-2 twitches post tetanic count Deep neuromuscular block: Deep neuromuscular block will be achieved with high dose rocuronium to achieve a depth of 1-2 twitches post tetanic count
Total
n=723 Participants
Total of all reporting groups
Age, Continuous
58.4 year
STANDARD_DEVIATION 13.7 • n=5 Participants
58.0 year
STANDARD_DEVIATION 13.5 • n=7 Participants
58.2 year
STANDARD_DEVIATION 13.6 • n=5 Participants
Sex: Female, Male
Female
150 Participants
n=5 Participants
139 Participants
n=7 Participants
289 Participants
n=5 Participants
Sex: Female, Male
Male
212 Participants
n=5 Participants
222 Participants
n=7 Participants
434 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
362 Participants
n=5 Participants
361 Participants
n=7 Participants
723 Participants
n=5 Participants

PRIMARY outcome

Timeframe: Day of surgery

The incidence of symptomatic intra-operative adverse events requiring intervention or treatment (ClassIntra®grade \>1) during laparoscopic surgery in the standard of care versus the deep NMB group, as scored by the attending surgeon and anesthesiologist at the end of every procedure. A recent update of the ClassIntra®grade also involved intraoperative adverse events related to anesthesia \[Gawria et al 2023\]. This study will use both the original classic scoring, as well as an adapted version of the updated classic scoring system. The Classic score; classification of intraoperative complications, is a 6 point scale ranging from no complications (0) to fatal complications (5).

Outcome measures

Outcome measures
Measure
Standard Neuromuscular Blockade
n=361 Participants
Subjects will receive regular rocuronium induction dose, followed by bolus foses of 10 mg in case of insufficient conditions
Deep Neuromuscular Block
n=362 Participants
Subjects will receive high dose rocuronium induction dose followed by continuous rocuronium administration, to achieve a depth of neuromuscular block of 1-2 twitches post tetanic count Deep neuromuscular block: Deep neuromuscular block will be achieved with high dose rocuronium to achieve a depth of 1-2 twitches post tetanic count
Classic Score>1
66 participants
54 participants

SECONDARY outcome

Timeframe: Day of surgery

To study the effect of deep neuromuscular block compared to standard neuromuscular block on peroperative surgical working conditions following the Leiden Surgical Rating scale (a 5 point scale, ranging from poor (1) to excellent (5) surgical conditions.

Outcome measures

Outcome measures
Measure
Standard Neuromuscular Blockade
n=361 Participants
Subjects will receive regular rocuronium induction dose, followed by bolus foses of 10 mg in case of insufficient conditions
Deep Neuromuscular Block
n=362 Participants
Subjects will receive high dose rocuronium induction dose followed by continuous rocuronium administration, to achieve a depth of neuromuscular block of 1-2 twitches post tetanic count Deep neuromuscular block: Deep neuromuscular block will be achieved with high dose rocuronium to achieve a depth of 1-2 twitches post tetanic count
L-SRS (Leiden Surgical Rating Scale)
4.6 units on a scale
Standard Deviation 0.5
4.9 units on a scale
Standard Deviation 0.3

SECONDARY outcome

Timeframe: 30 postoperative days

To study the effect of deep neuromuscular block compared to standard neuromuscular block on 30 day post-operative complications according the Clavien-Dindo score en Comprehensive Complication Index and unplanned readmissions

Outcome measures

Outcome measures
Measure
Standard Neuromuscular Blockade
n=361 Participants
Subjects will receive regular rocuronium induction dose, followed by bolus foses of 10 mg in case of insufficient conditions
Deep Neuromuscular Block
n=362 Participants
Subjects will receive high dose rocuronium induction dose followed by continuous rocuronium administration, to achieve a depth of neuromuscular block of 1-2 twitches post tetanic count Deep neuromuscular block: Deep neuromuscular block will be achieved with high dose rocuronium to achieve a depth of 1-2 twitches post tetanic count
30 Day Post-operative Complications
142 Participants
139 Participants

SECONDARY outcome

Timeframe: 2 postoperative days

To study the effect of deep neuromuscular block compared to standard neuromuscular block on Quality of Recovery at post-operative day 1, 2 according to the Quality of Recovery-40

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: 30 postoperative days

To study the effect of deep neuromuscular block compared to standard neuromuscular block on Quality of life at post-operative day 30 Short Form-36

Outcome measures

Outcome data not reported

Adverse Events

Standard Neuromuscular Blockade

Serious events: 24 serious events
Other events: 65 other events
Deaths: 0 deaths

Deep Neuromuscular Block

Serious events: 23 serious events
Other events: 51 other events
Deaths: 0 deaths

Serious adverse events

Serious adverse events
Measure
Standard Neuromuscular Blockade
n=361 participants at risk
Subjects will receive regular rocuronium induction dose, followed by bolus foses of 10 mg in case of insufficient conditions
Deep Neuromuscular Block
n=362 participants at risk
Subjects will receive high dose rocuronium induction dose followed by continuous rocuronium administration, to achieve a depth of neuromuscular block of 1-2 twitches post tetanic count Deep neuromuscular block: Deep neuromuscular block will be achieved with high dose rocuronium to achieve a depth of 1-2 twitches post tetanic count
Surgical and medical procedures
Unplanned readmission
6.6%
24/361 • 1 month
6.4%
23/362 • 1 month

Other adverse events

Other adverse events
Measure
Standard Neuromuscular Blockade
n=361 participants at risk
Subjects will receive regular rocuronium induction dose, followed by bolus foses of 10 mg in case of insufficient conditions
Deep Neuromuscular Block
n=362 participants at risk
Subjects will receive high dose rocuronium induction dose followed by continuous rocuronium administration, to achieve a depth of neuromuscular block of 1-2 twitches post tetanic count Deep neuromuscular block: Deep neuromuscular block will be achieved with high dose rocuronium to achieve a depth of 1-2 twitches post tetanic count
Gastrointestinal disorders
postoperative nausea vomiting
18.0%
65/361 • 1 month
14.1%
51/362 • 1 month

Additional Information

Martijn Boon MD PhD

LUMC

Phone: 003171522301

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place